Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.

E-GEOD-41441 - human placenta-derived cell line (JEG-3): Control vs. valproic acid(VPA)-treated

Status
Released on 11 October 2012, last updated on 3 May 2014
Organism
Homo sapiens
Samples (6)
Array (1)
Protocols (7)
Description
Transcriptional profiling of human placenta-derived JEG-3 cell line comparing vehicle control with 7.38 mM of valproic acid(VPA)-treated JEG-3 cells for 48 hr. 7.38 mM valproic acid(VPA) induced the 30% inhibiotion of JEG-3 cell proliferation, G1 phase cell cycle arrest and the reduction of cell size. The Goal was to analyze the mechanism of valproic acid-induced adverse effects in placental cells. Two-condition experiment, JEG-3 cells vs. valproic acid(VPA)-treated JEG-3 cells. Biological replicates: 3 control replicates, 3 VPA-treated replicates.
Experiment type
transcription profiling by array 
Contacts
Jae-Chun Ryu, Jina Lee, Youn-Jung Kim
MIAME
PlatformsProtocolsVariablesProcessedRaw
Files
Investigation descriptionE-GEOD-41441.idf.txt
Sample and data relationshipE-GEOD-41441.sdrf.txt
Raw data (1)E-GEOD-41441.raw.1.zip
Processed data (1)E-GEOD-41441.processed.1.zip
Array designA-AGIL-11.adf.txt
Links